Bone Biologics (BBLGW) Short Interest Ratio & Short Volume

Short interest is the volume of Bone Biologics shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 100 shares of BBLGW short. Learn More on Bone Biologics' current short interest.

Here is how the short interest of companies in the industry of "medical equipment" compare to Bone Biologics: Nyxoah S.A. (0.40%), Stevanato Group S.p.A. (9.07%), Zimmer Biomet Holdings, Inc. (3.37%), Solventum Co. (2.75%), Smith & Nephew plc (0.56%), Penumbra, Inc. (5.89%), Glaukos Co. (4.79%), Bausch + Lomb Co. (2.89%), Inspire Medical Systems, Inc. (6.51%), PROCEPT BioRobotics Co. (12.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($5.04 billion), T-Mobile US, Inc. ($4.49 billion), Charter Communications, Inc. ($3.25 billion), Moderna, Inc. ($3.02 billion), General Motors ($2.91 billion), Royal Caribbean Cruises Ltd. ($2.37 billion), Cencora, Inc. ($2.19 billion), Tractor Supply ($1.82 billion), Williams-Sonoma, Inc. ($1.72 billion), and Enphase Energy, Inc. ($1.61 billion). View all of the most shorted stocks.

Short selling BBLGW is an investing strategy that aims to generate trading profit from Bone Biologics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bone Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BBLGW, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBLGW, twice per month. The most recent reporting period available is June, 15 2024.